Evaluation of potential mechanisms underlying the safety observations of filgotinib in clinical studies in rheumatoid arthritis

被引：0
|
作者：
Clarke, A. [1 ]
Di Paolo, J. [1 ]
Downie, B. [1 ]
Meng, A. [1 ]
Mollova, N. [1 ]
Yu, Y. [1 ]
Han, P. [1 ]
机构：
[1] Gilead Sci Inc, Clin Dev, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P460
引用
收藏
页码：S409 / S409
页数：1
相关论文
共 50 条
  • [1] Evaluation of Potential Mechanisms Underlying the Safety Observations of Filgotinib in Clinical Studies in RA
    Di Paolo, Julie
    Downie, Bryan
    Meng, Amy
    Mollova, Nevena
    Yu, Yuanjiang
    Han, Pei
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] EVALUATION OF POTENTIAL MECHANISMS UNDERLYING THE SAFETY OBSERVATIONS OF FILGOTINIB IN CLINICAL STUDIES IN RA
    Clarke, Astrid
    Di Paolo, Julie
    Downie, Bryan
    Meng, Amy
    Mollova, Nevena
    Yu, Yuanjiang
    Han, Pei
    GASTROENTEROLOGY, 2020, 158 (06) : S1212 - S1212
  • [3] Safety of filgotinib in rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2024, 6 (07): : E421 - E421
  • [4] GEOGRAPHIC VARIATION OF SAFETY IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM
    Combe, B.
    Matsubara, T.
    Pechonkina, A.
    Tan, Y.
    Yin, Z.
    Hong, J.
    Besuyen, R.
    Gomez-Centeno, A.
    Buch, M. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 569 - 570
  • [5] Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis
    Combe, Bernard
    Besuyen, Robin
    Gomez-Centeno, Antonio
    Matsubara, Tsukasa
    Sancho Jimenez, Juan Jose
    Yin, Zhaoyu
    Buch, Maya H.
    RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 35 - 51
  • [6] Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis
    Bernard Combe
    Robin Besuyen
    Antonio Gómez-Centeno
    Tsukasa Matsubara
    Juan José Sancho Jimenez
    Zhaoyu Yin
    Maya H. Buch
    Rheumatology and Therapy, 2023, 10 : 35 - 51
  • [7] POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Bartok, Beatrix
    Winthrop, Kevin L.
    Genovese, Mark
    Combe, Bernard G.
    Tanaka, Yoshiya
    Kivitz, Alan
    Matzkies, Franziska
    Ye, Lei
    Guo, Ying
    Tasset, Chantal T.
    Sundy, John S.
    Keystone, Edward
    Westhovens, Rene
    Rigby, William
    Burmester, Gerd R.
    Walker, David R.
    GASTROENTEROLOGY, 2020, 158 (06) : S679 - S679
  • [8] Pooled safety analyses from Phase 3 studies of filgotinib in patients with rheumatoid arthritis
    Besuyen, R.
    Walker, D.
    Winthrop, K.
    Genovese, M.
    Combe, B.
    Tanaka, Y.
    Kivitz, A.
    Matzkies, F.
    Bartok, B.
    Ye, L.
    Guo, Y.
    Tasset, C.
    Sundy, J.
    Keystone, E.
    Westhovens, R.
    Rigby, W.
    Burmester, G.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S497 - S498
  • [9] Pooled Safety Analyses from Phase 3 Studies of Filgotinib in Patients with Rheumatoid Arthritis
    Winthrop, Kevin
    Genovese, Mark
    Combe, Bernard
    Tanaka, Yoshiya
    Kivitz, Alan
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John
    Keystone, Edward
    Westhovens, Rene
    Rigby, William F. C.
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [10] POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Valenzuela, C.
    Keystone, F.
    Winthrop, K.
    Genovese, H.
    Combe, B.
    Tanaka, Y.
    Kivitz, A.
    Matzkiess, F.
    Bartok, B.
    Ye, L.
    Guo, Y.
    Sundy, J.
    Tasset, C.
    Westhovens, R.
    Rigby, W.
    Burmester, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 127 - 127
12345